Do you use more stringent liver constraints when treating HCC with SBRT in patients who are CP B8/9 or C?

For example, will you lower the prescribed dose to achieve a lower mean liver dose?

Answer from: Radiation Oncologist at Academic Institution

CP C patients are typically excluded from SBRT studies due to unacceptably high toxicity risks. In my practice, I do not offer SBRT to CP C patients. For those with CP B8 or B9 cirrhosis, I aim to spare at least 700 cc of uninvolved liver from receiving 15 Gy or more when delivering 5-fraction SBRT....

Comments

Radiation Oncologist at Fox Chase Cancer Center
I agree with Dr. @Lin. In addition to high toxicit...

Please select the option that best describes you:

Do you use more stringent liver constraints when treating HCC with SBRT in patients who are CP B8/9 or C?

Related Questions